BridgeMD
Compares treatment options for Ultra Tension-Reducing Suture Technique
Official title A Self-Controlled Clinical Study of Fast-Absorbable Versus Slow-Absorbable Sutures Applied in Ultra Tension-Reducing Suture Technique
ClinicalTrials.gov ID: NCT07639372
What this study is testing
- What it's testing
- Hypertrophic scar formation after wound healing remains a clinical challenge in plastic surgery. Ultra Tension-Reducing Suture Technique is currently the primary surgical option for preventing and reducing hypertrophic scarring.An ideal tension-relieving effect requires sustained support for 3 months postoperatively to align with the natural recovery cycle of skin tissue tensile strength.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Incision length ≥ 5 cm;
- Clean, non-infected surgical wounds;
- Ability to provide written informed consent voluntarily;
- Scheduled for dermatologic surgery with intended linear wound closure;
- Able to complete required postoperative follow-up;
You likely can't join if
- Incision length ≤ 5 cm;
- Infected or contaminated wounds;
- Cognitive impairment precluding provision of independent informed consent;
- Pregnant women;
- Any other conditions judged inappropriate for enrollment by investigators.
See the full eligibility criteria
- Incision length ≥ 5 cm;
- Clean, non-infected surgical wounds;
- Ability to provide written informed consent voluntarily;
- Scheduled for dermatologic surgery with intended linear wound closure;
- Able to complete required postoperative follow-up;
- No restriction on surgical site.
- Incision length ≤ 5 cm;
- Infected or contaminated wounds;
- Cognitive impairment precluding provision of independent informed consent;
- Pregnant women;
- Any other conditions judged inappropriate for enrollment by investigators.
The study team makes the final eligibility decision.
Where it's taking place
- Lanzhou, Gansu, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lanzhou, Gansu, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.